Encompass Health Corporation EHC
123.47
1.46
1.20%
as of 25 Sep
- Market cap
- $12.0B
- P/E
- 19.9×
Follow EHC
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
18.64% | 18.84% | 19.68% | 19.30% | |
| 8.11% | 8.31% | 8.73% | 8.72% | ||
ROIC |
11.44% | 11.74% | 11.89% | 11.79% | |
Return on Tangible Assets |
13.40% | 13.57% | 13.94% | 13.77% | |
Average Days of Receivables |
38.47 | 38.08 | 40.67 | 40.42 | |
Free Cash Flow per Share |
4.01 | 4.37 | 4.68 | 4.18 | |
Free Cash Flow |
402.60 | 439.20 | 464.40 | 413.40 | |
Capital Expenditures |
(705.80) | (736.40) | (735.70) | (799.10) | |
Piotroski F-Score |
7.00 | 7.00 | 7.00 | 7.00 | |
| Other line items | |||||
Cash ROIC |
19.59% | 20.23% | 19.85% | 19.65% | |
Accounts Receivable Turnover |
9.76 | 9.75 | 9.34 | 9.55 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.20) | (0.20) | (0.21) | (0.20) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
61.19% | 60.76% | 60.50% | 60.09% | |
Share Based Compensation of Revenue |
0.87% | 0.95% | 0.96% | 0.93% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
2.05 | 2.08 | 1.97 | 1.95 | |
Depreciation/Fixed assets |
0.08 | 0.08 | 0.08 | 0.08 | |
Capex/Depreciation |
(2.14) | (2.18) | (2.13) | (2.24) | |
Revenue per Share |
57.67 | 59.06 | 61.15 | 62.81 | |
Operating CF per Share |
11.03 | 11.70 | 12.10 | 12.27 | |
Capex per Share |
(7.02) | (7.33) | (7.42) | (8.09) | |
Capex to Sales |
0.12 | 0.12 | 0.12 | 0.13 | |
Net Profit Margin |
9.33% | 9.54% | 10.04% | 10.01% |
Columns are period end dates